Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

101.66 +0.98 (+0.97%)
Official Closing Price Updated: 4:10 PM EDT, Jul 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
56 57 Next >
News headline image
3 High-Yielding Dividend Stocks That Can Help Bankroll Your Retirement Years ↗
These stocks provide good yields and they don't come with much risk. 
Via The Motley Fool
Topics Retirement
News headline image
7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio ↗
With political rumblings poised to make things exciting, investors may turn to the stability of trustworthy dividend stocks. 
Via InvestorPlace
News headline image
Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
Intuitive Surgical is an AI stock that you can buy and hold forever. Its business is health care; it makes profits, and health care is growing 
Via MarketBeat
Topics Artificial Intelligence
News headline image
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now? ↗
The big pharma company's top drug is losing ground, but its dividend keeps rising. 
Via The Motley Fool
News headline image
Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised ↗
The drugmaker slightly topped profit and sales forecasts. 
Via Investor's Business Daily
News headline image
Looking Into Abbott Laboratories's Recent Short Interest ↗
 
Via Benzinga
News headline image
10 Best Dividend Growth Stocks to Buy and Hold Forever ↗
Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance. 
Via The Motley Fool
News headline image
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review ↗
The Nasdaq tumbled amid chip woes. 
Via Investor's Business Daily
News headline image
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers ↗
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a... 
Via Benzinga
News headline image
Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims ↗
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the "Neutral" zone on Thursday. 
Via Benzinga
Topics Stocks
News headline image
7 Safe Stocks to Buy for Volatility Insurance ↗
Although not known for their riveting narratives, these safe stocks to buy can offer protection amid a growth-sector shakedown. 
Via InvestorPlace
News headline image
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript ↗
ABT earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Why Are Abbott Laboratories Shares Trading Lower? ↗
Shares of Abbott Laboratories (NYSE: ABT) are trading lower on Thursday following the company's announcement of its second-quarter 2024 financial results. 
Via Benzinga
News headline image
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views ↗
 
Via Benzinga
Topics Earnings
News headline image
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday? ↗
It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), often referred to as the market’s fear gauge, spiked over 10%, reaching levels... 
Via Benzinga
Topics Stocks
News headline image
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q2 2024 ↗
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Abbott Laboratories Q2 Earnings: Revenue And Profit Beat Estimates, Nudges Up Annual Profit Guidance On Strong Medical Devices Growth ↗
Abbott Laboratories reported Q2 sales of $10.38 billion, driven by 10.2% growth in Medical Devices, beating EPS estimates with $1.14 per share. Key highlights include FDA approval for two glucose... 
Via Benzinga
News headline image
Why This Leading Health Stock is a Buy No Matter the Market Move
Abbott's reliable dividend is more reliable than ever and is expected to continue growing at a high-single to low-double-digit CAGR. 
Via MarketBeat
News headline image
Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens ↗
Beaten-down stocks could make a comeback on Thursday, with Taiwan Semiconductor Manufacturing Company Ltd.’s (NYSE:TSM) strong quarterly repo 
Via Benzinga
Topics Economy
News headline image
2 Dividend Stocks to Buy and Hold Forever ↗
These stocks don't appeal only to dividend seekers. 
Via The Motley Fool
News headline image
Nasdaq Sees Worst Session Since 2022 As Chip Stocks Tumble After Trump's Taiwan Remarks and Biden's Potential Restrictions ↗
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the "Neutral" zone on Wednesday. 
Via Benzinga
Topics Government
News headline image
D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday ↗
 
Via Benzinga
News headline image
Abbott Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗
 
Via Benzinga
News headline image
Dow Closes At New High As Q2 Earnings Season Heats Up ↗
It’s a great start to the trading week. After months of trailing its major-index brethren, the Dow Jones reaches today’s closing bell at a new record high: 40,211. Q2 earnings are coming in well so... 
Via Talk Markets
Topics Stocks
News headline image
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years ↗
Following a lackluster big bank earnings, market participants now turn their attention to the unfolding week, expecting the trend to reverse. 
Via Benzinga
News headline image
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024 ↗
Explore undervalued healthcare stocks offering growth potential and stability in contrast to overvalued tech sector. 
Via InvestorPlace
News headline image
U.S. Cannabis Market Soars Amid Legal Reforms, But Safety Concerns Persist
From Financial Buzz Media
Via GlobeNewswire
News headline image
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns ↗
These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside. 
Via InvestorPlace
News headline image
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits ↗
Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt... 
Via Benzinga
Topics Lawsuit
News headline image
The 3 Best Healthcare Stocks to Buy in July 2024 ↗
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy. 
Via InvestorPlace
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.